Q2 2022 Holdings
Filed 2022-08-12 | 139 holdings | $52.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $14.5M | 537,958 | 27.9% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $10.5M | 897,359 | 20.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.9M | 61,237 | 17.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.0M | 60,000 | 9.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.8M | 246,554 | 9.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.3M | 250,000 | 4.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $1.5M | 375,000 | 2.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.0M | 944,431 | 1.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $991.0K | 1,680,552 | 1.9% |
| Anebulo Pharmaceuticals Inc(ANEB) | COM | 034569103 | $942.0K | 181,199 | 1.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $912.0K | 322,217 | 1.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $228.0K | 1,122 | 0.4% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $42.5K | 291,300 | 0.1% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $26.0K | 350,000 | 0.1% |
| Amgen Inc(AMGN)Call | COM | 031162100 | $24.3K | 100,000 | 0.0% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $22.9K | 112,200 | 0.0% |
| Axsome Therapeutics Inc(AXSM)Put | COM | 05464T104 | $19.2K | 500,000 | 0.0% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $16.6K | 616,700 | 0.0% |
| Celldex Therapeutics Inc New(CLDX)Call | COM NEW | 15117B202 | $13.7K | 506,500 | 0.0% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $13.4K | 350,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $13.1K | 2,054,602 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $12.8K | 160,116 | 0.0% |
| Karuna Therapeutics IncPut | COM | 48576A100 | $12.7K | 100,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $12.7K | 100,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $11.6K | 1,408,116 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $11.3K | 40,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $9.4K | 40,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $9.4K | 1,018,327 | 0.0% |
| Kezar Life Sciences IncCall | COM | 49372L100 | $8.9K | 1,075,300 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $8.8K | 106,700 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $8.4K | 1,000,387 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $8.2K | 1,379,422 | 0.0% |
| Sage Therapeutics Inc(SG7)Call | COM | 78667J108 | $8.1K | 250,000 | 0.0% |
| Horizon Therapeutics PUB LCall | SHS | G46188101 | $8.0K | 100,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $7.5K | 100,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.3K | 239,441 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX)Call | COM | 03237H101 | $6.8K | 350,800 | 0.0% |
| Lantheus Hldgs Inc(LNTH)Call | COM | 516544103 | $6.6K | 100,000 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY)Put | COM | 02043Q107 | $5.8K | 39,900 | 0.0% |
| Relmada Therapeutics Inc(RLMD)Call | COM | 75955J402 | $5.7K | 300,000 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $5.6K | 2,788,853 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $5.6K | 123,200 | 0.0% |
| Relmada Therapeutics Inc(RLMD)Put | COM | 75955J402 | $5.4K | 282,300 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $4.9K | 162,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.9K | 225,991 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD)Call | COM | 45845P108 | $4.8K | 350,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.8K | 86,865 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $4.3K | 884,008 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $4.2K | 86,035 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $4.2K | 80,000 | 0.0% |